| 2024-03-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 5,783 0.0053% | $956.47 | $5.53M | +0.82% | |
| 2023-12-05 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 6,536 0.0061% | $817.44 | $5.34M | +15.93% | |
| 2023-11-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 6,492 0.0061% | $799.17 | $5.19M | +19.14% | |
| 2022-11-15 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 3,720 0.0035% | $727.81 | $2.71M | +4.71% | |
| 2022-08-15 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 766 0.0007% | $648.78 | $496,965 | +15.37% | |
| 2022-05-16 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 472 0.0004% | $663.60 | $313,219 | +11.64% | |
| 2022-02-15 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 3,540 0.0033% | $629.34 | $2.23M | +9.79% | |
| 2021-12-10 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 7,122 0.0067% | $666.27 | $4.75M | -4.5% | |
| 2021-11-16 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 7,167 0.0068% | $647.17 | $4.64M | -1.19% | |
| 2020-11-17 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 6,628 0.0063% | $542.73 | $3.6M | -3.83% | |
| 2020-07-14 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 6,309 0.0059% | $627.51 | $3.96M | -19.29% | |
| 2020-07-13 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 8,000 0.0077% | $628.50 | $5.03M | -15.97% | |
| 2020-01-27 | Sale | Regeneron Pharmaceuticals, Inc. REGN | EVP Research | 8,000 0.0073% | $340.91 | $2.73M | +64.42% |